Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identifying and addressing unmet clinical needs in primary cutaneous B-cell lymphoma: A consensus-based paper from an ad-hoc international panel.
Quaglino P, Pimpinelli N, Zinzani PL, Paulli M, Pileri S, Berti E, Cerroni L, Guitart J, Kim YH, Rupoli S, Santucci M, Simontacchi G, Vermeer M, Hoppe R, Pro B, Swerdlow SH, Barosi G. Quaglino P, et al. Among authors: rupoli s. Hematol Oncol. 2024 Jan;42(1):e3215. doi: 10.1002/hon.3215. Epub 2023 Aug 30. Hematol Oncol. 2024. PMID: 37649350
Clinicopathological, cytogenetic, and molecular profiles of primary cutaneous diffuse large B-cell lymphomas.
Uccella S, Goteri G, Maiorana A, Donati V, Tibiletti MG, Magnoli F, Facchi S, Merchiori D, Morsia E, Papotti R, Bettelli S, Forti E, Galimberti S, Rupoli S, Filosa A, Dardanis D, Bomben R, Braglia L, Pozzi S, Sacchi S. Uccella S, et al. Among authors: rupoli s. Hum Pathol. 2023 Jun;136:44-55. doi: 10.1016/j.humpath.2023.03.012. Epub 2023 Mar 28. Hum Pathol. 2023. PMID: 36997030 Free article.
Prognosis in early stage cutaneous T-cell lymphoma treated with psoralen plus ultraviolet A irradiation and low-dose interferon-α: Long-term efficacy and survival according to conventional and emerging clinical endpoints.
Rupoli S, Goteri G, Morsia E, Torre E, Giantomassi F, Campanati A, Offidani AM, Molinelli E, Brandozzi G, Serresi S, Giacchetti A, Bugatti L, Filosa G, Mozzicafreddo G, Simonacci M, Olivieri A. Rupoli S, et al. Dermatol Ther. 2022 Oct;35(10):e15737. doi: 10.1111/dth.15737. Epub 2022 Aug 9. Dermatol Ther. 2022. PMID: 35903895
99 results